Clinical Trial Update: A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on CD22-targeted CAR-T for B cell malignancies across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• CD22-targeted CAR-T (CD22-targeted CAR-T)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN